Symposium
Chairs: Ioannis Kalomenidis (Athens, GR), Julius P. Janssen (Nijmegen, NL)

Phenotyping malignant pleural effusions: why? Gary Yc Lee (Perth, WA, Australia)
TIME for a change in practice: insights from the TIME 1, 2, and 3 trials Najib M. Rahman (Oxford, United Kingdom)
Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial. Rahul Bhatnagar (Bristol, United Kingdom)
Bevacizumab-targeted therapy for malignant pleural mesothelioma Arnaud Scherpereel (Lille, France)